Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-079700

Director sold 47,702 shares at $0.91 ($43,447)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Menzel Garry E Director 2023-07-10 Sale −47,702 $0.91 $43,447 75,056 D
Open-market sales · 47,702 sh · avg $0.91 · $43,447
Loading xslF345X04/tm2320966-1_4seq1.xml…